Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2138387 | Leukemia Research | 2010 | 4 Pages |
Abstract
Over-expression of multidrug resistance (MDR) proteins PGP and BCRP has a negative prognostic impact in acute myeloid leukemia (AML) patients. Inclusion of fludarabine in induction chemotherapy increases remission rate in PGP over-expressing cases. We investigated the role of BCRP in 138 adult AML patients receiving induction therapy with fludarabine. None of the MDR-related proteins influenced complete remission attainment. Conversely, high levels of BCRP significantly affected disease-free survival, as higher relapse rates (48.5% vs 28.5%) and earlier relapse occurred in BCRP+ patients. Also overall survival was affected by BCRP positivity, and survival significantly worsened in case of concomitant PGP and BCRP over-expression.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Daniela Damiani, Mario Tiribelli, Angela Michelutti, Antonella Geromin, Margherita Cavallin, Dora Fabbro, Annalisa Pianta, Michele Malagola, Giuseppe Damante, Domenico Russo, Renato Fanin,